elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Lymphoma
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Lymphoma
RIS
0.002
(Research Intensity Score)
Papers
303
Top papers
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial
2022 · 781 citations
Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies
2021 · 198 citations
Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma
2017 · 2333 citations
Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis
2025 · 16 citations
Scavenging Reactive Oxygen Species by Cerium Oxide Nanoparticles Prevents Death in a Peripheral T Cell Lymphoma Preclinical Mouse Model
2025 · 10 citations
161 Tb Radioimmunotherapy as a Treatment for CD30-Positive Lymphomas
2025 · 8 citations
Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials
2021 · 70 citations
C-X-C Motif Chemokine Receptor 4–Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma
2022 · 51 citations
Prospective phase II trial of first-line rituximab, methotrexate, and orelabrutinib (R-MO) in primary central nervous system lymphoma
2025 · 8 citations
Newest papers
Identification of Molecular Biomarkers of Diffuse Large B-Cell Lymphoma Through Gold Nanoparticle-Based Surface-Enhanced Raman Spectroscopy (SERS) Coupled with Multivariate Analysis
2026 · 2 citations
Evaluating the impact of partial volume correction on FDG PET radiomics stability in lymphoma lesions
2026 · 2 citations
Vitreoretinal Lymphoma: A Comprehensive Clinical Review and Current Standards in Management
2026
Highlights from the 2025 ASH meeting: what’s new in lymphoma?
2026
Multi-omics analysis identifies GAA as an independent poor prognostic biomarker and candidate therapeutic target in angioimmunoblastic T-cell lymphoma
2026
Immunological changes in the circulation of cancer patients in response to 10- and 30-min acute exercise
2026
Real-world efficacy and safety of golidocitinib in 3 patients with relapsed/refractory peripheral T-cell lymphoma
2026
Primary Pulmonary Diffuse Large B-cell Lymphoma
2026
Case Report: Probable CLIPPERS in a patient with cutaneous T-cell lymphoma in remission: 5-year follow-up
2026
Browse all papers →
Lymphoma's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Lymphoma's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link